Detalhe da pesquisa
1.
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Cell
; 176(4): 775-789.e18, 2019 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30595452
2.
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Cell
; 181(3): 747, 2020 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32359441
3.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36477031
4.
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Lancet Oncol
; 25(4): 509-517, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38547894
5.
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.
Cancer
; 130(3): 433-438, 2024 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37788133
6.
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Ann Surg Oncol
; 2024 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38762644
7.
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
Ann Surg Oncol
; 31(3): 1857-1864, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37966706
8.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35129464
9.
Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.
Ann Surg Oncol
; 30(8): 5017-5026, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36991168
10.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36203067
11.
Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma.
J Surg Oncol
; 127(5): 841-847, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36573839
12.
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.
Future Oncol
; 19(30): 2017-2027, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37665297
13.
External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort.
Ann Surg Oncol
; 29(3): 1637-1644, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34816368
14.
Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
Ann Surg Oncol
; 29(11): 7010-7017, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35676603
15.
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
Ann Surg Oncol
; 29(2): 791-801, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34648098
16.
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Ann Surg Oncol
; 29(6): 3694-3708, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35089452
17.
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial.
BMC Cancer
; 22(1): 851, 2022 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35927710
18.
Outcome after treatment for sebaceous carcinoma: A multicenter study.
J Surg Oncol
; 125(4): 730-735, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34990031
19.
Merkel Cell Carcinoma, the Impact of Clinical Excision Margins and Mohs Micrographic Surgery on Recurrence and Survival: A Systematic Review.
Dermatol Surg
; 48(4): 387-394, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35165221
20.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 643-654, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33857412